Studies demonstrated high sensitivity and specificity, comparable to PCR, with potential for point-of-care use. 5,7 CRISPR-based assays have shown promise in the diagnosis of different pathogens ...

Vertex Pharmaceuticals (VRTX) stock gains as England opts to reimburse its CRSPR (CRSP)-partnered gene therapy Casgevy to ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

Human Papilloma Virus (HPV) self-sampling promises to make the process of screening for cervical cancer easier, more ...